Evidence map›Paper›PMID 29134197›Full record

ArticleScience advances2017

Directed differentiation of human pluripotent stem cells to blood-brain barrier endothelial cells.

Tongcheng Qian, Shaenah E Maguire, Scott G Canfield, Xiaoping Bao, William R Olson, Eric V Shusta, Sean P Palecek

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 151 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
151citing papers in PubMed, 1 pooled it
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

151 citing papers in PubMed, 1 synthesis or guideline pooled it, 270 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

91 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Tongcheng QianDepartment of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, WI 53706, USA.ORCID 0000-0002-9071-3543
Shaenah E MaguireDepartment of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, WI 53706, USA.ORCID 0000-0002-2693-953X
Scott G CanfieldDepartment of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, WI 53706, USA.ORCID 0000-0003-1328-7365
Xiaoping BaoDepartment of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, WI 53706, USA.ORCID 0000-0003-0955-6868
William R OlsonDepartment of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, WI 53706, USA.ORCID 0000-0002-7704-0823
Eric V ShustaDepartment of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, WI 53706, USA.ORCID 0000-0002-4297-0158
Sean P PalecekDepartment of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, WI 53706, USA.ORCID 0000-0003-4917-5584
University of Wisconsin–Madison · US

Funding

Regulating human pluripotent stem cell differentiation by colony confinementR01EB007534 · NIBIB · UNIVERSITY OF WISCONSIN-MADISON · PI PALECEK, SEAN P · 2007 to 2019
$4.1M
RXRalpha and PPARdelta Signaling as Novel Regulators of the Blood-Brain BarrierR01NS083688 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI SHUSTA, ERIC V · 2013 to 2017
$1.9M
Shear regulated differentiation of hPSCs to brain endothelial cellsR21NS085351 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI PALECEK, SEAN P · 2013 to 2014
$407k
NIBIB NIH HHS R01 EB007534NINDS NIH HHS R01 NS083688NINDS NIH HHS R21 NS085351
6 · The paper itself

Abstract

The blood-brain barrier (BBB) is composed of specialized endothelial cells that are critical to neurological health. A key tool for understanding human BBB development and its role in neurological disease is a reliable and scalable source of functional brain microvascular endothelial cells (BMECs). Human pluripotent stem cells (hPSCs) can theoretically generate unlimited quantities of any cell lineage in vitro, including BMECs, for disease modeling, drug screening, and cell-based therapies. We demonstrate a facile, chemically defined method to differentiate hPSCs to BMECs in a developmentally relevant progression via small-molecule activation of key signaling pathways. hPSCs are first induced to mesoderm commitment by activating canonical Wnt signaling. Next, these mesoderm precursors progress to endothelial progenitors, and treatment with retinoic acid leads to acquisition of BBB-specific markers and phenotypes. hPSC-derived BMECs generated via this protocol exhibit endothelial properties, including tube formation and low-density lipoprotein uptake, as well as efflux transporter activities characteristic of BMECs. Notably, these cells exhibit high transendothelial electrical resistance above 3000 ohm·cm

Indexed as

Cell DifferentiationBlood-Brain BarrierCell LineageClaudin-5Coculture TechniquesElectric ImpedanceEndothelial CellsHumansPhenotypePluripotent Stem CellsTranscription FactorsTranscriptomeClaudin-5Transcription Factors

Identifiers

PMID29134197
PMCPMC5677350
OpenAlexW2767330810

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.